Track agilon health, inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

agilon health, inc. AGL · Stock Open agilon health, inc. in new tab

115.66 USD
EPS
-6.69
P/B
6.92
ROE
-36.15
Beta
3.11
Target Price
120.25 USD
agilon health, inc. logo

agilon health, inc.

🧾 Earnings Recap – Q3 2025

Agilon Health's Q3 2025 showed revenue of $1.44 billion, but continued challenges resulted in a negative medical margin of $57 million and adjusted EBITDA of negative $91 million. The company is focused on improving performance through enhanced data analytics and revisiting its guidance for 2025.

  • Revenue for Q3 2025 reached $1.44 billion, impacted by lower-than-expected risk scores and high costs from exited markets.
  • The company has reinstated 2025 guidance, projecting a revenue midpoint of $5.82 billion and an adjusted EBITDA of negative $258 million.
  • Enhanced data pipeline now supports 80% of members with timely analytics, positioning agilon for improved forecasting and operational efficiencies.
  • Approximately 75% of agilon's members are expected to be in plans rated 4 stars or higher for 2026, outperforming the broader Medicare Advantage average.
  • The company is proactively negotiating payer contracts for 2026, focusing on improved terms and profitability, even at the potential expense of reduced membership.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 24, 2027
EPS-6.69
Book Value16.72
Price to Book6.92
Debt/Equity11.90
% Insiders5.241%
Growth
Revenue Growth0.06%
Earnings Growth3.01%
Estimates
Forward P/E23.36
Forward EPS4.95
Target Mean Price120.25

DCF valuation

Model fair value for agilon health, inc. (AGL)
Result
Sign in to run the valuation for AGL.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
12 analysts · consensus Buy · mean target 120.25 USD (low 85.00, high 146.00) · as of 14 Nov 2026
Low 85.00
Mean 120.25
High 146.00
Price 115.66
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

agilon health, inc. Logo agilon health, inc. Analysis (AGL)

United States Health Care Official Website Stock

Is agilon health, inc. a good investment? agilon health, inc. (AGL) is currently trading at 115.66 USD. Market analysts have a consensus price target of 120.25 USD. This suggests a potential upside from current levels.

Earnings Schedule: agilon health, inc. is expected to release its next earnings report on Feb. 24, 2027. The market consensus estimate for Forward EPS is 4.95.

Investor FAQ

Does agilon health, inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is agilon health, inc.?

agilon health, inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Feb. 24, 2027. The company currently has a trailing EPS of -6.69.

Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

Exchange Ticker
NYQ (United States) AGL
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2011
0.07 USD
Dec. 1, 2011 0.0180
Sept. 1, 2011 0.0180
June 1, 2011 0.0180
March 1, 2011 0.0180
▸2010
0.07 USD
Dec. 1, 2010 0.0176
Sept. 1, 2010 0.0176
June 1, 2010 0.0176
March 1, 2010 0.0176
▸2009
0.03 USD
Dec. 1, 2009 0.0172
Sept. 1, 2009 0.0172
Stock Splits
Split Date Split Ratio to 1
March 31, 2026 1:25
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion